Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 3:35 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 3409–3432 of 121,499 matching trials from the live ClinicalTrials.gov search.

Filters: Completed Clear all

Conditions: Atherosclerosis, Type 2 Diabetes (T2D)
Interventions: Not listed
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 279 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Pre Diabetes, Diabetes
Interventions: Diabetes Prevention Program, Healthy Living Program; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 4
States / cities: Rochester, New York

Conditions: Descending Aortic Dissection, Postoperative Pain, Thoracoabdominal Aortic Aneurysm
Interventions: Saline, Ketamine; Drug
Lead sponsor: Eric Johnson; Other
Eligibility: 18 Years to 90 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Breast- Female
Interventions: Radioactive Seed Localization, Wire Localization; Procedure
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 20 Years to 99 Years · Female only
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Adenoma Colon
Interventions: Simethicone Solution, Polyethylenglycol; Drug · Other
Lead sponsor: Texas Tech University Health Sciences Center, El Paso; Other
Eligibility: 30 Years to 80 Years
Enrollment: 268 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: El Paso, Texas

Conditions: Osteopetrosis
Interventions: Interferon gamma-1b; Drug
Lead sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center; Other
Eligibility: 1 Year and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 2
States / cities: Torrance, California • Minneapolis, Minnesota

Conditions: Multiple Sclerosis, Traumatic Brain Injury
Interventions: Emotional Processing Training, Placebo Control; Behavioral
Lead sponsor: Kessler Foundation; Other
Eligibility: 18 Years to 65 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: East Hanover, New Jersey

Conditions: Diabetes
Interventions: Glargine insulin; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 22 Years to 70 Years
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Adrenocortical Carcinoma, Localized Resectable Neuroblastoma, Precancerous Condition
Interventions: computed tomography, 3-Tesla magnetic resonance imaging, Abdominal Sonogram; Procedure
Lead sponsor: Children's Oncology Group; Network
Eligibility: Up to 6 Months
Enrollment: 97 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2013
U.S. locations: 38
States / cities: Tucson, Arizona • Downey, California • Los Angeles, California + 35 more

Conditions: Osteoporosis, Prostate Cancer
Interventions: Calcium, Zoledronic acid, radiation therapy, LHRH, Vitamin D; Dietary Supplement · Radiation · Drug
Lead sponsor: Radiation Therapy Oncology Group; Network
Eligibility: 18 Years and older · Male only
Enrollment: 109 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2014
U.S. locations: 80
States / cities: Chico, California • Los Angeles, California • Pomona, California + 66 more

Conditions: Functional Constipation in Children
Interventions: Fiber, Placebo; Other
Lead sponsor: Warren Bishop; Other
Eligibility: 2 Years to 16 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Healthy
Interventions: HPG1860; Drug
Lead sponsor: Hepagene (Shanghai) Co., Ltd.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Type 1 Diabetes Mellitus
Interventions: Blood Glucose Awareness Training; Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 21 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Other Abortion, Spontaneous Abortion
Interventions: Gabapentin, Placebo; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Depressive Disorder, Major Depressive Disorder
Interventions: Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR); Drug
Lead sponsor: Wyeth is now a wholly owned subsidiary of Pfizer; Industry
Eligibility: 7 Years to 18 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 9
States / cities: Little Rock, Arkansas • North Miami, Florida • Terre Haute, Indiana + 6 more

Conditions: Autism Spectrum Disorder, Moderate Language Delay
Interventions: Direct Instruction-Language for Learning (DI-LL) via telehealth (e.g., Zoom or WebEx), Standard of care delivered via telehealth (e.g., Zoom or WebEx); Behavioral
Lead sponsor: Emory University; Other
Eligibility: 4 Years to 7 Years
Enrollment: 137 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Pain, Postoperative
Interventions: Fentanyl, Naltrexone; Drug
Lead sponsor: Incline Therapeutics, Inc.; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Fargo, North Dakota

Conditions: Acute Coronary Syndrome, Depression, Myocardial Infarction, Unstable Angina, STEMI, NSTEMI - Non-ST Segment Elevation MI
Interventions: Individual Interview; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 35 Years to 85 Years
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Prostate Cancer
Interventions: docetaxel, leuprolide acetate, radiation therapy; Drug · Radiation
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years to 120 Years · Male only
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2012
U.S. locations: 2
States / cities: Chapel Hill, North Carolina • Raleigh, North Carolina

Conditions: Brain Mapping, Deafness, Healthy
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: Not listed
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1998 – 2000
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Schizophrenia
Interventions: SEP-363856, Placebo - Cap; Drug
Lead sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.; Industry
Eligibility: 18 Years to 40 Years
Enrollment: 245 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 6
States / cities: Little Rock, Arkansas • Garden Grove, California • Pico Rivera, California + 3 more

Conditions: Psychosis
Interventions: Family Focused Treatment, Enhanced Care; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 12 Years to 35 Years
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 7
States / cities: Los Angeles, California • San Diego, California • New Haven, Connecticut + 4 more

Conditions: Bladder Cancer
Interventions: aminophylline; Drug
Lead sponsor: University of Virginia; Other
Eligibility: 40 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Glabellar Lines
Interventions: Formulation A: OnabotulinumtoxinA, Formulation B: OnabotulinumtoxinA, Formulation C: OnabotulinumtoxinA; Drug
Lead sponsor: Allergan; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 5
States / cities: Glendale, Arizona • Coral Gables, Florida • New Orleans, Louisiana + 2 more

Search by objective public record fields.

Arsenic, Disordered Glucose Homeostasis and Atherosclerosis

Comparing Diabetes Prevention Programs

Ketamine in Patients Undergoing TEVAR Procedures Receiving NCI

A Trial of RSL Versus WL for Malignant Breast Disease

Effect of Simethicone on Screening Colonoscopy

ACTIMMUNE in Intermediate Osteopetrosis

Remediation of Emotional Deficits in Multiple Sclerosis and Traumatic Brain Injury

Comparison of SoloSTAR With a Syringe-administered Glargine Insulin in Diabetic Patients From the Hospital

Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging

Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy

Constipation Fiber Trial

Study of Safety, Tolerability and PK, PD of HPG1860 in Healthy Subjects

Feasibility and Efficacy of Delivering Blood Glucose Awareness Training Over the Internet

Gabapentin as an Adjunct to Perioperative Pain Management Regimens for Uterine Aspiration

Study Evaluating Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR) In The Treatment Of Child and Adolescent Outpatients With Major Depressive Disorder

Direct Instruction Language for Learning in Autism Spectrum Disorder

Pharmacokinetic Characterization of the Active, Separated System With PK Controller (Fentanyl Iontophoretic Transdermal System, 40 Mcg Fentanyl Per Activation).

MBCT Delivered Via Group Videoconferencing for ACS Patients With Elevated Depression Symptoms

Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer

Areas of Brain Responsible for Understanding American Sign Language

A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia

Prevention Trial of Family Focused Treatment in Youth at Risk for Psychosis

Study of BCG + Aminophylline Toxicity When Used in the Treatment of Bladder Cancer

A Study of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines